Perflutren lipid microsphere injectable suspension for cardiac ultrasound

Sahar S. Abdelmoneim; Sharon L. Mulvagh

doi:10.2217/iim.12.11

Perflutren lipid microsphere injectable suspension for cardiac ultrasound

Sahar S. Abdelmoneim, Sharon L. Mulvagh

Cardiovascular Medicine

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Echocardiography is a widely available noninvasive procedure for diagnosing cardiovascular disease. With the development of clinically useful microbubble contrast agents to enhance echocardiographic images and advantages of portability without radiation, microbubble contrast agents have become essential established adjunctive tools to perform state-of-the-art echocardiography. Several manufacturers produce commercially available stabilized microbubbles for intravenous use. Perflutren lipid microsphere (DEFINITY®) is one of the second generation microbubble contrast agents approved for left ventricular opacification and left ventricular endocardial border detection, and is the subject of this review.

Original language	English (US)
Pages (from-to)	171-191
Number of pages	21
Journal	Imaging in Medicine
Volume	4
Issue number	2
DOIs	https://doi.org/10.2217/iim.12.11
State	Published - Apr 2012

Keywords

contrast echocardiography
endocardial border definition
left ventricular opacification
perflutren lipid microsphere
stress echocardiography
ultrasound microbubble contrast agents

ASJC Scopus subject areas

Radiological and Ultrasound Technology
Radiology Nuclear Medicine and imaging

Access to Document

10.2217/iim.12.11

Cite this

@article{b89f4f0d308347abb54ab95f73a72837,

title = "Perflutren lipid microsphere injectable suspension for cardiac ultrasound",

abstract = "Echocardiography is a widely available noninvasive procedure for diagnosing cardiovascular disease. With the development of clinically useful microbubble contrast agents to enhance echocardiographic images and advantages of portability without radiation, microbubble contrast agents have become essential established adjunctive tools to perform state-of-the-art echocardiography. Several manufacturers produce commercially available stabilized microbubbles for intravenous use. Perflutren lipid microsphere (DEFINITY{\textregistered}) is one of the second generation microbubble contrast agents approved for left ventricular opacification and left ventricular endocardial border detection, and is the subject of this review.",

keywords = "contrast echocardiography, endocardial border definition, left ventricular opacification, perflutren lipid microsphere, stress echocardiography, ultrasound microbubble contrast agents",

author = "Abdelmoneim, {Sahar S.} and Mulvagh, {Sharon L.}",

year = "2012",

month = apr,

doi = "10.2217/iim.12.11",

language = "English (US)",

volume = "4",

pages = "171--191",

journal = "Imaging in Medicine",

issn = "1755-5191",

publisher = "Future Medicine Ltd.",

number = "2",

}

TY - JOUR

T1 - Perflutren lipid microsphere injectable suspension for cardiac ultrasound

AU - Abdelmoneim, Sahar S.

AU - Mulvagh, Sharon L.

PY - 2012/4

Y1 - 2012/4

N2 - Echocardiography is a widely available noninvasive procedure for diagnosing cardiovascular disease. With the development of clinically useful microbubble contrast agents to enhance echocardiographic images and advantages of portability without radiation, microbubble contrast agents have become essential established adjunctive tools to perform state-of-the-art echocardiography. Several manufacturers produce commercially available stabilized microbubbles for intravenous use. Perflutren lipid microsphere (DEFINITY®) is one of the second generation microbubble contrast agents approved for left ventricular opacification and left ventricular endocardial border detection, and is the subject of this review.

AB - Echocardiography is a widely available noninvasive procedure for diagnosing cardiovascular disease. With the development of clinically useful microbubble contrast agents to enhance echocardiographic images and advantages of portability without radiation, microbubble contrast agents have become essential established adjunctive tools to perform state-of-the-art echocardiography. Several manufacturers produce commercially available stabilized microbubbles for intravenous use. Perflutren lipid microsphere (DEFINITY®) is one of the second generation microbubble contrast agents approved for left ventricular opacification and left ventricular endocardial border detection, and is the subject of this review.

KW - contrast echocardiography

KW - endocardial border definition

KW - left ventricular opacification

KW - perflutren lipid microsphere

KW - stress echocardiography

KW - ultrasound microbubble contrast agents

UR - http://www.scopus.com/inward/record.url?scp=84860187186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860187186&partnerID=8YFLogxK

U2 - 10.2217/iim.12.11

DO - 10.2217/iim.12.11

M3 - Article

AN - SCOPUS:84860187186

SN - 1755-5191

VL - 4

SP - 171

EP - 191

JO - Imaging in Medicine

JF - Imaging in Medicine

IS - 2

ER -

Perflutren lipid microsphere injectable suspension for cardiac ultrasound

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this